NSD2 and Miyoshi myopathy: In this study, GLIPR1 expression was found to be lower in MM patients belonging to the hyperdiploid (HY) and low bone disease (LB) UAMS molecular subgroups compared to the MAF, MMSET and Cyclin translocation subgroups, although the mechanisms underlying these associations remain unclear.